APA (7th ed.) Citation

Taha, T., Abu-sini, H., & Billan, S. (2022). Tyrosine kinase inhibitor treatment and long-term follow-up for metastatic malignant struma ovarii. Pediatric Hematology & Oncology, 39(8), 769. https://doi.org/10.1080/08880018.2022.2064021

Chicago Style (17th ed.) Citation

Taha, Tarek, Hosam Abu-sini, and Salem Billan. "Tyrosine Kinase Inhibitor Treatment and Long-term Follow-up for Metastatic Malignant Struma Ovarii." Pediatric Hematology & Oncology 39, no. 8 (2022): 769. https://doi.org/10.1080/08880018.2022.2064021.

MLA (9th ed.) Citation

Taha, Tarek, et al. "Tyrosine Kinase Inhibitor Treatment and Long-term Follow-up for Metastatic Malignant Struma Ovarii." Pediatric Hematology & Oncology, vol. 39, no. 8, 2022, p. 769, https://doi.org/10.1080/08880018.2022.2064021.